PTGS2-899G>C and prostate cancer risk: a population-based nested case-control study (ProtecT) and a systematic review with meta-analysis.
Prostaglandin endoperoxidase synthase 2 is a key regulator of inflammation and may play a role in prostate carcinogenesis. The polymorphism, -899G>C (rs20417), alters a transcription factor-binding site and is associated with a reduced risk of colorectal adenoma. We tested the hypothesis that...
প্রধান লেখক: | Murad, A, Lewis, S, Smith, G, Collin, S, Chen, L, Hamdy, F, Neal, D, Donovan, J, Martin, R |
---|---|
বিন্যাস: | Journal article |
ভাষা: | English |
প্রকাশিত: |
2009
|
অনুরূপ উপাদানগুলি
অনুরূপ উপাদানগুলি
-
Alcohol consumption and PSA-detected prostate cancer risk--a case-control nested in the ProtecT study.
অনুযায়ী: Zuccolo, L, অন্যান্য
প্রকাশিত: (2013) -
Prostate Testing for Cancer and Treatment (ProtecT) feasibility study
অনুযায়ী: J. Donovan, অন্যান্য
প্রকাশিত: (2003-01-01) -
The ProtecT trial - Evaluating the effectiveness of treatment for clinically localised prostate cancer (ISRCTN20141297)
অনুযায়ী: Lane, J, অন্যান্য
প্রকাশিত: (2004) -
Associations of sexual dysfunction symptoms with PSA-detected localised and advanced prostate cancer: a case-control study nested within the UK population-based ProtecT (Prostate testing for cancer and Treatment) study.
অনুযায়ী: Collin, S, অন্যান্য
প্রকাশিত: (2009) -
The protecT (prostate testing for cancer and treatment) study: Evaluating screening and treatment of clinically localised prostate cancer in the UK
অনুযায়ী: Hamdy, F, অন্যান্য
প্রকাশিত: (2006)